LH Youkeles, JN Grizzanti, Z Liao, CJ Chang and DL Rosenstreich
Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461.

Pulmonary eosinophilic granuloma is a disorder caused by localized collections of proliferating histiocytes in the lung. Little is known about its etiology except that the majority (58 to 97%) of patients are current or ex-smokers, making the potential etiologic role of tobacco products an important area for research. Tobacco glycoprotein (TGP) is a potent immunostimulator that has been isolated from cigarette smoke. TGP-specific lymphocyte proliferation, and cytokine production in vitro, were measured in three patients with pulmonary eosinophilic granuloma in remission and in three closely matched normal subjects with similar smoking histories. One patient with eosinophilic granuloma of bone and a matched control subject were also studied. Peripheral blood mononuclear cells were cultured with TGP, the recall antigen streptokinase (SK), and the mitogen concanavalin A (Con A). All three of the patients with pulmonary eosinophilic granuloma exhibited significant decreases in lymphocyte stimulation to TGP, despite normal responses to SK and Con A. In contrast, the response of the patient with eosinophilic granuloma of bone was higher than her matched control. The mean responses of the patients with pulmonary eosinophilic granuloma to TGP was significantly lower than the mean of nondiseased smokers or of normal nonsmokers. Twenty-four-hour culture supernatants were collected and assayed for cytokine levels (IL-1, IL-2, and IL-6). TGP-stimulated IL-2 production was significantly lower in the patients with pulmonary eosinophilic granuloma than in the normal subjects, confirming the reduced T-cell proliferative response.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				J. P. Lynch III Rare Interstitial Lung Diseases: Pulmonary Langerhans Cell Histiocytosis, Lymphangioleiomyomatosis, and Cryptogenic Organizing Pneumonia ACCP Pulmonary Med Brd Rev, January 1, 2009; 25(0): 585 - 618. [Full Text] [PDF]

				A. Tazi Adult pulmonary Langerhans' cell histiocytosis. Eur. Respir. J., June 1, 2006; 27(6): 1272 - 1285. [Abstract] [Full Text] [PDF]

				A. Caminati and S. Harari Smoking-related Interstitial Pneumonias and Pulmonary Langerhans Cell Histiocytosis. Proceedings of the ATS, January 1, 2006; 3(4): 299 - 306. [Abstract] [Full Text] [PDF]

				K. Vermaelen and R. Pauwels Pulmonary Dendritic Cells Am. J. Respir. Crit. Care Med., September 1, 2005; 172(5): 530 - 551. [Abstract] [Full Text] [PDF]

				M. Selman The Spectrum of Smoking-Related Interstitial Lung Disorders: The Never-Ending Story of Smoke and Disease Chest, October 1, 2003; 124(4): 1185 - 1187. [Full Text] [PDF]

				K. M. Sundar, M. V. Gosselin, H. L. Chung, and B. C. Cahill Pulmonary Langerhans Cell Histiocytosis: Emerging Concepts in Pathobiology, Radiology, and Clinical Evolution of Disease Chest, May 1, 2003; 123(5): 1673 - 1683. [Abstract] [Full Text] [PDF]

				R. Vassallo, J. H. Ryu, T. V. Colby, T. Hartman, and A. H. Limper Pulmonary Langerhans'-Cell Histiocytosis N. Engl. J. Med., June 29, 2000; 342(26): 1969 - 1978. [Full Text] [PDF]

				A. Tazi, P. Soler, and A. J Hance Rare diseases bullet 9: Adult pulmonary Langerhans' cell histiocytosis Thorax, May 1, 2000; 55(5): 405 - 416. [Full Text]

				G. R. Epler and E. J. Mark Case 11-1998- A 35-Year-Old Woman with Obstructive Pulmonary Disease and Cystic Changes on CT Scans of the Chest N. Engl. J. Med., April 9, 1998; 338(15): 1051 - 1058. [Full Text] [PDF]